FI20021626A - Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi - Google Patents

Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi Download PDF

Info

Publication number
FI20021626A
FI20021626A FI20021626A FI20021626A FI20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A
Authority
FI
Finland
Prior art keywords
hcv
hepatitis
antibodies
virus
detection
Prior art date
Application number
FI20021626A
Other languages
English (en)
Swedish (sv)
Other versions
FI111645B (fi
Inventor
David Y Chien
William Rutter
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of FI20021626A publication Critical patent/FI20021626A/fi
Application granted granted Critical
Publication of FI111645B publication Critical patent/FI111645B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI20021626A 1991-06-24 2002-09-11 Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi FI111645B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72248991A 1991-06-24 1991-06-24
US72248991 1991-06-24
PCT/US1992/005388 WO1993000365A2 (en) 1991-06-24 1992-06-24 Hepatitis c virus (hcv) polypeptides
US9205388 1992-06-24

Publications (2)

Publication Number Publication Date
FI20021626A true FI20021626A (fi) 2002-09-11
FI111645B FI111645B (fi) 2003-08-29

Family

ID=24902063

Family Applications (2)

Application Number Title Priority Date Filing Date
FI935808A FI110099B (fi) 1991-06-24 1993-12-22 Menetelmä hepatiitti C-viruksen (HCV) polypeptidien valmistamiseksi
FI20021626A FI111645B (fi) 1991-06-24 2002-09-11 Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI935808A FI110099B (fi) 1991-06-24 1993-12-22 Menetelmä hepatiitti C-viruksen (HCV) polypeptidien valmistamiseksi

Country Status (16)

Country Link
US (2) US6346375B1 (fi)
EP (1) EP0591431B1 (fi)
JP (9) JP3516681B2 (fi)
KR (1) KR0185426B1 (fi)
AT (1) ATE229543T1 (fi)
BG (1) BG61843B1 (fi)
CA (1) CA2110058C (fi)
DE (1) DE69232871T2 (fi)
ES (1) ES2188583T3 (fi)
FI (2) FI110099B (fi)
HU (1) HU227547B1 (fi)
NO (1) NO309528B1 (fi)
RO (1) RO117329B1 (fi)
RU (1) RU2148587C1 (fi)
UA (1) UA40572C2 (fi)
WO (1) WO1993000365A2 (fi)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5698390A (en) 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
GB9204274D0 (en) * 1992-02-28 1992-04-08 Wellcome Found Novel peptides
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
EP0984068B1 (en) 1993-04-27 2012-03-28 Innogenetics N.V. Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
PL175360B1 (pl) * 1993-05-10 1998-12-31 Chiron Corp Cząsteczka kwasu nukleinowego i kompozycja do wykrywania infekcji wirusa zapalenia wątroby typu C
ATE249838T1 (de) 1993-05-12 2003-10-15 Chiron Corp Konserviertes motiv der hepatitis c virus e2/ns1 region
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5639856A (en) 1993-09-13 1997-06-17 The Regents Of The University Of California Semaphorin gene family
AU8003894A (en) * 1993-10-29 1995-05-22 Srl Inc. Antigen peptide compound and immunoassay method
ATE290592T1 (de) * 1993-11-04 2005-03-15 Innogenetics Nv Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
WO1996013590A2 (en) * 1994-10-21 1996-05-09 Innogenetics N.V. New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
JPH08333390A (ja) * 1995-04-07 1996-12-17 Hoechst Japan Ltd ペプチド及びそれからなる自己免疫疾患治療剤
EP0829488A4 (en) * 1995-04-28 1999-04-07 Srl Inc ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD
GB9513261D0 (en) * 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
ATE311463T1 (de) * 1996-05-24 2005-12-15 Chiron Corp Fusionsprotein mit multiplen epitopen
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
ES2316171T3 (es) 1997-09-22 2009-04-01 Novartis Vaccines And Diagnostics, Inc. Tampones para estabilizar antigenos hcv.
ES2310701T3 (es) * 1998-04-17 2009-01-16 Innogenetics N.V. Metodos para mejorar la conformacion de proteinas por medio de agentes reductores.
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
US7052696B2 (en) * 1998-07-10 2006-05-30 The United States Of America As Represented By The Department Of Health And Human Services Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
US6191256B1 (en) * 1998-11-20 2001-02-20 Bayer Corporation Recombinant factor VIII binding peptides
CA2377525A1 (en) * 1999-07-19 2001-03-29 Epimmune, Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
US20070031446A1 (en) 2003-07-11 2007-02-08 Intercell Ag Hcv vaccines
US6630298B2 (en) 2000-06-15 2003-10-07 Chiron Corporation HCV antigen/antibody combination assay
KR100801123B1 (ko) 2000-08-17 2008-02-05 트리펩 아베 리바비린 함유 백신 및 이것의 사용 방법
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
EP1195381A1 (de) * 2000-09-28 2002-04-10 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
MXPA03009632A (es) 2001-04-24 2004-06-30 Innogenetics Nv Proteinas de la envoltura de vhc glucosiladas en la estructura central.
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20030100467A1 (en) * 2001-09-12 2003-05-29 Wolfgang Aehle Binding phenol oxidizing enzyme-peptide complexes
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
WO2003073097A2 (en) * 2002-02-28 2003-09-04 Intercell Ag Methods for isolating ligands e.g. t cell epitopes
AU2003218111B8 (en) * 2002-03-11 2008-11-20 Lab 21 Limited Methods and compositions for identifying and characterizing hepatitis C
AU2003301865A1 (en) * 2002-05-16 2004-06-07 The General Hospital Corporation Epitopes of hepatitis c virus
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
CA2484941A1 (en) 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
ES2312806T3 (es) 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
US7378234B2 (en) 2002-09-13 2008-05-27 Intercell Ag Method for isolating hepatitis C virus peptides
EP2287311A1 (en) * 2003-03-04 2011-02-23 Intercell AG Streptococcus pyogenes antigens
AU2004224746B2 (en) 2003-03-24 2009-04-23 Valneva Austria Gmbh Improved vaccines
WO2004084937A1 (en) * 2003-03-24 2004-10-07 Intercell Ag Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
EP2311991A1 (en) 2003-04-15 2011-04-20 Intercell AG S. pneumoniae antigens
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
WO2005010035A2 (en) * 2003-07-22 2005-02-03 Branch Andrea D Alternate reading frame polypeptides derived from hepatitis c and methods of their use
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
FR2859909B1 (fr) 2003-09-22 2007-09-07 Biomerieux Sa Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation
CA2558963A1 (en) * 2004-04-16 2005-12-15 Genentech, Inc. Omi pdz modulators
EP1802778B1 (en) * 2004-08-27 2011-10-05 Novartis Vaccines and Diagnostics, Inc. Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
JP4897792B2 (ja) 2005-04-20 2012-03-14 ビロメッド カンパニー， リミテッド 融合タンパク質の分離のための組成物および方法
US7968697B2 (en) * 2005-05-25 2011-06-28 Chrontech Pharma Ab Hepatitis C virus non-structural NS3/4A fusion gene
CA2661492A1 (en) 2006-08-25 2008-02-28 Novartis Ag Hcv fusion polypeptides
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20090214593A1 (en) * 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
US8815253B2 (en) 2007-12-07 2014-08-26 Novartis Ag Compositions for inducing immune responses
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
US9636410B2 (en) 2011-07-06 2017-05-02 Glaxosmithkline Biologicals Sa Cationic oil-in-water emulsions
US9655845B2 (en) 2011-07-06 2017-05-23 Glaxosmithkline Biologicals, S.A. Oil-in-water emulsions that contain nucleic acids
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
WO2013150450A1 (en) * 2012-04-02 2013-10-10 Universidade Do Porto Hcv homolog fragments, cell-lines and applications thereof
EP3564384A1 (en) 2013-03-14 2019-11-06 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
CN105228649B (zh) 2013-03-14 2019-01-18 雅培制药有限公司 Hcv抗原-抗体组合测定和方法以及用在其中的组合物
EP2970947A4 (en) 2013-03-14 2016-10-12 Abbott Lab RECOMBINANT HCV NS3 ANTIGENS AND THEIR MUTANTS FOR ENHANCED ANTIBODY DETECTION
ES2832335T3 (es) 2015-03-27 2021-06-10 Ortho Clinical Diagnostics Inc Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
CN111153963B (zh) * 2020-01-19 2021-08-10 华南理工大学 抗炎五肽及其提取分离方法和在改善记忆中的应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
DE3886363T3 (de) * 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
GB2212511B (en) 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
AU650038B2 (en) 1988-03-11 1994-06-09 Abbott Laboratories CKS method of protein synthesis
US5312737A (en) 1988-03-11 1994-05-17 Abbott Laboratories CKS method of HCV protein synthesis
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
EP0416725A3 (en) 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
JP2818761B2 (ja) 1989-09-14 1998-10-30 財団法人化学及血清療法研究所 非ａ非ｂ型肝炎ウイルス抗原をコードする核酸断片およびその利用法
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
LU87861A1 (fr) * 1989-12-18 1991-10-08 Wellcome Found Agent viral
JPH03190898A (ja) 1989-12-21 1991-08-20 Shima Kenkyusho:Kk 合成ポリペプチド及びそれを用いたｈｃｖ抗体測定試薬
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
EP0435229A1 (en) 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
EP0527788B1 (en) 1990-04-04 2004-06-30 Chiron Corporation Hepatitis c virus protease
ES2152922T3 (es) * 1990-04-06 2001-02-16 Genelabs Tech Inc Epitopos del virus de la hepatitis c.
JPH044880A (ja) 1990-04-20 1992-01-09 Terumasa Arima 非ａ非ｂ型肝炎抗原をコードするｄｎａ及びポリペプチド
JP3268502B2 (ja) 1990-06-12 2002-03-25 徹雄 中村 非ａ非ｂ型肝炎ウイルス関連ポリヌクレオチド、ポリペプ タイド
JPH0446196A (ja) 1990-06-13 1992-02-17 Kuraray Co Ltd 抗原蛋白質およびそれをコードしているｄｎａ断片
AU652941B2 (en) 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
EP0933426A1 (en) 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
EP0468657A3 (en) 1990-07-09 1992-02-05 Tonen Corporation Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
JPH04126086A (ja) 1990-07-12 1992-04-27 Yamanouchi Pharmaceut Co Ltd 非ａ非ｂ型肝炎ウイルス抗原ポリペプチド、該抗原ポリペプチドをコードするポリヌクレオチド、及びそれらを用いた非ａ非ｂ型肝炎の診断法
CA2047792C (en) 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
CZ282573B6 (cs) 1990-08-10 1997-08-13 Chiron Corporation Způsob detekce HCV sekvence, souprava a reakční činidlo pro detekci HCV
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
CA2090335A1 (en) 1990-08-25 1992-02-26 Suzanne Zebedee Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
JP3055793B2 (ja) 1990-09-07 2000-06-26 財団法人化学及血清療法研究所 非ａ非ｂ型肝炎ウイルス融合ペプチドおよびその製法
JPH04144686A (ja) 1990-10-04 1992-05-19 Kunitada Shimotoono 構造蛋白質遺伝子、組換えベクター、それにより形質転換された大腸菌、ポリペプチドおよびポリペプチドの製造方法
JPH04159298A (ja) 1990-10-19 1992-06-02 Olympus Optical Co Ltd Ｈｃｖペプチド
DE59109221D1 (de) 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
EP0485209A1 (en) 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
JPH04179482A (ja) 1990-11-11 1992-06-26 Kunitada Shimotoono Ｃ型肝炎ウイルス由来の遺伝子
JPH04187090A (ja) 1990-11-22 1992-07-03 Toshio Shikata 非ａ非ｂ型肝炎抗原をコードするｄｎａ及びポリペプチド
WO1992009634A1 (en) 1990-11-29 1992-06-11 Toray Industries, Incorporated Non-a non-b hepatitis virus antigen protein
DE69029092T2 (de) * 1990-12-14 1997-04-17 Innogenetics N.V., Gent Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
KR930703361A (ko) 1991-01-31 1993-11-29 찰스 엠. 브룩 추정의 c형 간염 바이러스(hcv) 외막 영역에 대한 모노클로날 항체 및 이의 사용 방법
JP3244284B2 (ja) 1991-02-14 2002-01-07 武田薬品工業株式会社 Ｃ型肝炎ウイルス関連抗体および抗原の測定法
US5574132A (en) 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
JPH0568562A (ja) 1991-05-30 1993-03-23 Sanwa Kagaku Kenkyusho Co Ltd ヒトＣ型肝炎ウイルスのｃＤＮＡ、そのクローン及びこれらの利用法
JP3055964B2 (ja) 1991-05-31 2000-06-26 株式会社トクヤマ Ｈｃｖ 抗原活性ポリペプチド、ポリペプチドの製造方法、形質転換された大腸菌、および抗ｈｃｖ 抗体の検出方法
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
BR9206131A (pt) 1991-06-10 1995-05-02 Lucky Ltd Hepatite C: diagnóstico e vacinas
CA2070952A1 (en) 1991-06-11 1992-12-12 Makoto Seki Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
AU648912B2 (en) 1991-06-13 1994-05-05 Dade International Inc. Immunoassay for non-A non-B hepatitis
JP3103180B2 (ja) 1992-01-30 2000-10-23 昭和電工株式会社 軟質性合成樹脂製シート
JP3190898B2 (ja) 1998-11-09 2001-07-23 米沢日本電気株式会社 ノート型パーソナルコンピュータ

Also Published As

Publication number Publication date
JP3514751B2 (ja) 2004-03-31
JP3516681B2 (ja) 2004-04-05
JPH06508837A (ja) 1994-10-06
FI935808A0 (fi) 1993-12-22
JP2008001716A (ja) 2008-01-10
JP4456595B2 (ja) 2010-04-28
RO117329B1 (ro) 2002-01-30
FI935808A (fi) 1994-02-21
WO1993000365A3 (en) 1993-04-29
CA2110058A1 (en) 1993-01-07
JP2005053920A (ja) 2005-03-03
HU9303703D0 (en) 1994-04-28
WO1993000365A2 (en) 1993-01-07
KR0185426B1 (ko) 1999-04-01
JP4456596B2 (ja) 2010-04-28
NO934542D0 (no) 1993-12-10
EP0591431B1 (en) 2002-12-11
FI111645B (fi) 2003-08-29
CA2110058C (en) 2001-09-25
BG98332A (bg) 1995-02-28
ES2188583T3 (es) 2003-07-01
JP3926817B2 (ja) 2007-06-06
JP2003277396A (ja) 2003-10-02
JP2007077168A (ja) 2007-03-29
UA40572C2 (uk) 2001-08-15
US6150087A (en) 2000-11-21
HUT73098A (en) 1996-06-28
DE69232871D1 (de) 2003-01-30
NO309528B1 (no) 2001-02-12
JP3619827B2 (ja) 2005-02-16
BG61843B1 (bg) 1998-07-31
JP2009084285A (ja) 2009-04-23
EP0591431A1 (en) 1994-04-13
JP2000139485A (ja) 2000-05-23
NO934542L (no) 1994-02-10
JP2004115533A (ja) 2004-04-15
AU2305392A (en) 1993-01-25
HU227547B1 (en) 2011-08-29
AU671594B2 (en) 1996-09-05
FI110099B (fi) 2002-11-29
RU2148587C1 (ru) 2000-05-10
ATE229543T1 (de) 2002-12-15
DE69232871T2 (de) 2003-05-08
JP3514680B2 (ja) 2004-03-31
US6346375B1 (en) 2002-02-12
JP2007131629A (ja) 2007-05-31

Similar Documents

Publication Publication Date Title
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
NO870412L (no) Peptider.
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE69131707D1 (de) Nachweis von Hepatits C mit Verwendung rekombinanter Antigene
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

MA Patent expired